SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-080508
Filing Date
2024-09-20
Accepted
2024-09-20 11:50:30
Documents
15
Period of Report
2024-09-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0215232-8k_onconetix.htm   iXBRL 8-K 32722
2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO ea021523201ex3-1_onconetix.htm EX-3.1 5815
3 PRESS RELEASE, DATED SEPTEMBER 20, 2024 ea021523201ex99-1_onconetix.htm EX-99.1 19549
  Complete submission text file 0001213900-24-080508.txt   244684

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE onco-20240920.xsd EX-101.SCH 3042
5 XBRL LABEL FILE onco-20240920_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE onco-20240920_pre.xml EX-101.PRE 22377
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0215232-8k_onconetix_htm.xml XML 3798
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 241312322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)